Citadel Advisors’s Omnicell OMCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,900
| Closed | -$494K | – | 13856 |
|
|
2025
Q4 | $494K | Buy |
10,900
+1,100
| +11% | +$40.2K | ﹤0.01% | 9053 |
|
|
2025
Q3 | $298K | Sell |
9,800
-9,900
| -50% | -$304K | ﹤0.01% | 10383 |
|
|
2025
Q2 | $579K | Sell |
19,700
-7,000
| -26% | -$209K | ﹤0.01% | 8304 |
|
|
2025
Q1 | $933K | Buy |
26,700
+6,800
| +34% | +$270K | ﹤0.01% | 7112 |
|
|
2024
Q4 | $886K | Sell |
19,900
-7,100
| -26% | -$319K | ﹤0.01% | 7300 |
|
|
2024
Q3 | $1.18M | Buy |
27,000
+10,500
| +64% | +$396K | ﹤0.01% | 6533 |
|
|
2024
Q2 | $447K | Buy |
16,500
+3,800
| +30% | +$110K | ﹤0.01% | 8284 |
|
|
2024
Q1 | $371K | Buy |
12,700
+2,400
| +23% | +$72.8K | ﹤0.01% | 9006 |
|
|
2023
Q4 | $388K | Sell |
10,300
-24,500
| -70% | -$901K | ﹤0.01% | 8635 |
|
|
2023
Q3 | $1.57M | Sell |
34,800
-25,200
| -42% | -$1.53M | ﹤0.01% | 5667 |
|
|
2023
Q2 | $4.42M | Buy |
60,000
+42,200
| +237% | +$2.85M | ﹤0.01% | 3835 |
|
|
2023
Q1 | $1.04M | Buy |
17,800
+8,900
| +100% | +$491K | ﹤0.01% | 6688 |
|
|
2022
Q4 | $449K | Sell |
8,900
-29,300
| -77% | -$1.76M | ﹤0.01% | 8472 |
|
|
2022
Q3 | $3.33M | Buy |
38,200
+23,700
| +163% | +$2.49M | ﹤0.01% | 4596 |
|
|
2022
Q2 | $1.65M | Buy |
14,500
+4,100
| +39% | +$471K | ﹤0.01% | 5945 |
|
|
2022
Q1 | $1.35M | Buy |
10,400
+600
| +6% | +$86.5K | ﹤0.01% | 6995 |
|
|
2021
Q4 | $1.77M | Buy |
9,800
+5,400
| +123% | +$937K | ﹤0.01% | 6531 |
|
|
2021
Q3 | $653K | Sell |
4,400
-15,700
| -78% | -$2.41M | ﹤0.01% | 9240 |
|
|
2021
Q2 | $3.04M | Sell |
20,100
-1,100
| -5% | -$153K | ﹤0.01% | 5566 |
|
|
2021
Q1 | $2.75M | Sell |
21,200
-9,400
| -31% | -$1.21M | ﹤0.01% | 5645 |
|
|
2020
Q4 | $3.67M | Buy |
30,600
+8,900
| +41% | +$873K | ﹤0.01% | 4228 |
|
|
2020
Q3 | $1.62M | Buy |
21,700
+9,300
| +75% | +$645K | ﹤0.01% | 5125 |
|
|
2020
Q2 | $876K | Buy |
12,400
+7,500
| +153% | +$513K | ﹤0.01% | 6063 |
|
|
2020
Q1 | $321K | Sell |
4,900
-3,000
| -38% | -$239K | ﹤0.01% | 7209 |
|
|
2019
Q4 | $646K | Sell |
7,900
-6,900
| -47% | -$529K | ﹤0.01% | 6385 |
|
|
2019
Q3 | $1.07M | Sell |
14,800
-400
| -3% | -$29.4K | ﹤0.01% | 5485 |
|
|
2019
Q2 | $1.31M | Buy |
15,200
+8,600
| +130% | +$699K | ﹤0.01% | 5269 |
|
|
2019
Q1 | $534K | Sell |
6,600
-600
| -8% | -$44.9K | ﹤0.01% | 6677 |
|
|
2018
Q4 | $441K | Sell |
7,200
-3,200
| -31% | -$217K | ﹤0.01% | 6592 |
|
|
2018
Q3 | $748K | Sell |
10,400
-3,500
| -25% | -$220K | ﹤0.01% | 6037 |
|
|
2018
Q2 | $729K | Buy |
+13,900
| New | +$654K | ﹤0.01% | 5756 |
|
|
2018
Q1 | – | Sell |
-6,700
| Closed | -$325K | – | 8630 |
|
|
2017
Q4 | $325K | Buy |
+6,700
| New | +$338K | ﹤0.01% | 6329 |
|
|
2016
Q1 | – | Sell |
-1,500
| Closed | -$47K | – | 7616 |
|
|
2015
Q4 | $47K | Sell |
1,500
-2,300
| -61% | -$67.9K | ﹤0.01% | 7370 |
|
|
2015
Q3 | $118K | Sell |
3,800
-3,100
| -45% | -$111K | ﹤0.01% | 6795 |
|
|
2015
Q2 | $260K | Buy |
6,900
+5,600
| +431% | +$204K | ﹤0.01% | 5951 |
|
|
2015
Q1 | $46K | Buy |
1,300
+1,200
| +1,200% | +$39.6K | ﹤0.01% | 7431 |
|
|
2014
Q4 | $3K | Buy |
+100
| New | +$3.09K | ﹤0.01% | 8338 |
|
|
2014
Q2 | – | Sell |
-2,300
| Closed | -$66K | – | 8199 |
|
|
2014
Q1 | $66K | Buy |
2,300
+300
| +15% | +$8.21K | ﹤0.01% | 6538 |
|
|
2013
Q4 | $51K | Sell |
2,000
-100
| -5% | -$2.39K | ﹤0.01% | 6021 |
|
|
2013
Q3 | $50K | Sell |
2,100
-9,600
| -82% | -$214K | ﹤0.01% | 5792 |
|
|
2013
Q2 | $240K | Buy |
+11,700
| New | +$216K | ﹤0.01% | 4502 |
|
Other funds holding OMCL
VPM
VCM
NAMI
Citadel Advisors's OMCL Position: Q1 2026 in Review
Citadel Advisors sold out of Omnicell (OMCL) in Q1 2026, closing a stake of 252,062 shares — an estimated $11.4M sold.
Citadel Advisors first reported a position in OMCL in Q2 2013 and held it in 39 quarters. The position peaked at $30.2M in Q3 2022. 272 funds tracked by Wall St. Rank hold OMCL as of Q1 2026.
- Citadel Advisors reported no remaining Omnicell position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 252,062 Omnicell shares in Q1 2026, an estimated $11.4M.
- Citadel Advisors first reported a position in Omnicell in Q2 2013 and held it in 39 quarters.
- Citadel Advisors's Omnicell position peaked at $30.2M in Q3 2022.
- 272 funds tracked by Wall St. Rank held Omnicell as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.